Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.49 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.49 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.49 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | GALR3 | O60755 | 2/20 | 0.43 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TNF | P01375 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19486460 | 0.82 | TSHR (0.82) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL15605424 | 0.81 | TSHR (1.00) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL13052935 | 0.81 | TSHR (0.74) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL13080878 | 0.80 | TSHR (0.73) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL15631604 | 0.79 | TSHR (0.71) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL21128383 | 0.78 | TSHR (0.69) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL13826722 | 0.77 | HTT (0.67) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL19486091 | 0.76 | TSHR (0.67) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL6565325 | 0.76 | TSHR (0.67) | TSHRMAPK1HTTPIK3CDPIK3CA | |
| SCHEMBL63585 | 0.76 | HTT (0.71) | TSHRMAPK1HTTPIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230371360-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230348510-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230002430-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, TPO | TSHR 1568/4885MAPK1 3104/4885HTT 656/4885 |
| US-20230371360-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | CHRM1, L1CAM, SOD1 | TSHR 1035/4885MAPK1 190/4885HTT 3464/4885 |
| US-20230002430-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | CHRM1, L1CAM, SOD1 | TSHR 1025/4885MAPK1 201/4885HTT 3485/4885 |
| US-20230348510-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OXER1, OXSR1 | TSHR 312/4885MAPK1 842/4885HTT 4619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.